Key facts
- This page summarizes Jeffrey N. Simmons's Form 4 filing for Elanco Animal Health Inc (ELAN).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 03 Dec 2024, 17:03.
Jeffrey N. Simmons - 29 Nov 2024 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)
- Reporting relationship
- PRESIDENT, CEO AND DIRECTOR, Director
- Issuer ticker
- ELAN
- Reported as of
- 29 Nov 2024
- Net transaction value
- +$2,769
- SEC form
- 4
- Accepted by SEC
- 03 Dec 2024, 17:03:03 UTC
- Prior SEC filing
- 19 Nov 2024
- Next SEC filing
- 17 Dec 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Amy C. Seidel, as Attorney-in-Fact for Jeffrey N. Simmons
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jeffrey N. Simmons filed Form 4 for Elanco Animal Health Inc (ELAN) on 03 Dec 2024.
Change
- Previous filing in this sequence was filed on 19 Nov 2024.
- Current net transaction value: +$2,769.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ELAN
transaction
Derivative
Deferred Stock Units
Award
- Transaction value
- $2,769
- Shares
- +210
- Change %
- +4.8%
- Price
- $13.21
- Shares after
- 4,534
- Date
- 29 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 210
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
Footnote F2
Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.